Phathom Pharmaceuticals, Inc. (PHAT) — 8-K Filings

8-K Filings (21)

• 8-K Filing — Apr 30, 2026
• 8-K Filing — Nov 4, 2025
• Phathom Pharmaceuticals Files 8-K — Oct 27, 2025 Risk: medium
  Phathom Pharmaceuticals, Inc. filed an 8-K on October 27, 2025, reporting an "Other Event" as of October 25, 2025. The filing does not contain specific details
• Phathom Pharmaceuticals Reports Officer and Director Changes — Oct 6, 2025 Risk: medium
  Phathom Pharmaceuticals, Inc. filed an 8-K on October 6, 2025, reporting changes effective October 2, 2025. The filing pertains to the departure of directors or
• Phathom Pharmaceuticals Files 8-K on Financials — Aug 7, 2025 Risk: low
  Phathom Pharmaceuticals, Inc. filed an 8-K on August 7, 2025, reporting on its results of operations and financial condition. The filing includes financial stat
• Phathom Pharmaceuticals Files 8-K — Jun 16, 2025 Risk: medium
  Phathom Pharmaceuticals, Inc. filed an 8-K on June 16, 2025, reporting an "Other Event." The filing does not contain specific details about the event, dollar am
• Phathom Pharmaceuticals Files 8-K on Security Holder Vote — Jun 9, 2025 Risk: medium
  Phathom Pharmaceuticals, Inc. filed an 8-K on June 9, 2025, reporting on a matter submitted to a vote of its security holders on June 3, 2025. The filing does n
• Phathom Pharmaceuticals Files 8-K — Jun 6, 2025 Risk: low
  On June 6, 2025, Phathom Pharmaceuticals, Inc. filed an 8-K report detailing a Regulation FD Disclosure and Other Events. The filing also includes financial sta
• Phathom Pharmaceuticals Files 8-K — May 1, 2025 Risk: low
  Phathom Pharmaceuticals, Inc. filed an 8-K on May 1, 2025, reporting on its results of operations and financial condition, as well as presenting financial state
• Phathom Pharmaceuticals Announces Board and Executive Changes — Apr 16, 2025 Risk: medium
  Phathom Pharmaceuticals, Inc. announced on April 11, 2025, changes in its board of directors and executive compensation arrangements. The filing details the dep
• Phathom Pharmaceuticals Announces Executive & Director Changes — Apr 1, 2025 Risk: medium
  Phathom Pharmaceuticals, Inc. filed an 8-K on April 1, 2025, reporting changes effective March 31, 2025. The filing indicates a departure of directors or certai
• Phathom Pharmaceuticals Files 8-K on Financials — Mar 6, 2025 Risk: low
  Phathom Pharmaceuticals, Inc. filed an 8-K on March 6, 2025, reporting on its results of operations and financial condition. The filing includes financial state
• Phathom Pharmaceuticals Files 8-K — Dec 11, 2024 Risk: low
  On December 11, 2024, Phathom Pharmaceuticals, Inc. filed an 8-K report. The filing indicates "Other Events" as the primary item of disclosure. No specific deta
• Phathom Pharmaceuticals Files 8-K on Financials — Nov 7, 2024 Risk: low
  On November 7, 2024, Phathom Pharmaceuticals, Inc. filed an 8-K report. The filing pertains to the company's results of operations and financial condition, as w
• Phathom Pharmaceuticals Files 8-K — Aug 19, 2024 Risk: low
  Phathom Pharmaceuticals, Inc. filed an 8-K on August 19, 2024, to report other events and financial statements/exhibits. The filing does not contain specific de
• Phathom Pharmaceuticals Files 8-K on Financials — Aug 8, 2024 Risk: low
  On August 8, 2024, Phathom Pharmaceuticals, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition,
• Phathom Pharmaceuticals Files 8-K Report — Jul 18, 2024 Risk: medium
  On July 18, 2024, Phathom Pharmaceuticals, Inc. filed an 8-K report. The filing indicates an 'Other Event' without specifying further details in the provided te
• Astellas to Acquire Phathom Pharmaceuticals for $177M — May 24, 2024 Risk: medium
  Phathom Pharmaceuticals, Inc. announced on May 23, 2024, that it has entered into a definitive agreement to be acquired by an affiliate of Astellas Pharma Inc.
• Phathom Pharmaceuticals Files 8-K — May 9, 2024 Risk: low
  Phathom Pharmaceuticals, Inc. filed an 8-K on May 9, 2024, reporting on its results of operations and financial condition, as well as financial statements and e
• Phathom Pharmaceuticals Files 8-K — Mar 7, 2024 Risk: low
  Phathom Pharmaceuticals, Inc. filed an 8-K on March 7, 2024, to report on its results of operations and financial condition, as well as to file financial statem
• Phathom Pharma Files 8-K for 'Other Event' on Feb 13 — Feb 13, 2024 Risk: medium
  Phathom Pharmaceuticals, Inc. filed an 8-K on February 13, 2024, reporting an 'Other Event'. The filing provides standard company identification details for the

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX